| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/13/2013 | CN102960729A Peanut skin extract for regulating activity of amylolytic enzyme and preparation method of extract |
| 03/13/2013 | CN102960564A Method for producing angelica sinensis cow and sheep products |
| 03/13/2013 | CN102960497A Blood-sugar reducing, kidney invigorating and health caring tea |
| 03/13/2013 | CN102960488A Health care weight reducing tea used for simple obesity |
| 03/13/2013 | CN102960450A Health care horse milk |
| 03/13/2013 | CN102960301A Method for producing ginseng cow and sheep products |
| 03/13/2013 | CN102960183A Artificial culture method for Cordyceps sinensis and Cordyceps sinensis product |
| 03/13/2013 | CN102552251B Pharmaceutical composition containing 17 amino acids |
| 03/13/2013 | CN102475682B 小檗碱脂质体及其制备方法 Berberine liposomes and its preparation method |
| 03/13/2013 | CN102362864B Method for raising free-flowing property and bulk density of vitamin A or vitamin D3 microcapsules |
| 03/13/2013 | CN102349937B Preparation method of ixeris sonchifolia hance extractive |
| 03/13/2013 | CN102344880B Health wine and production method thereof |
| 03/13/2013 | CN102327340B Chinese medicine granular preparation for poultry and preparation method thereof |
| 03/13/2013 | CN102274471B Medicinal composition for treating diabetes |
| 03/13/2013 | CN102274247B Laminaria polysaccharide japonica capsules and preparation method and application thereof |
| 03/13/2013 | CN102228536B Chinese herbal extract for treating diabetic nephropathy and preparation method thereof |
| 03/13/2013 | CN102225149B Traditional Chinese medicine compound for treating diabetes and preparation method thereof |
| 03/13/2013 | CN102210873B Application of C10orf116 genes in preparing medicament for improving insulin sensitivity of adipose tissue |
| 03/13/2013 | CN102178786B Medicament combination for treating diabetic peripheral neuropathy as well as preparation method and application thereof |
| 03/13/2013 | CN102153536B Mangiferin aglycon derivative, as well as preparation method and application of the mangiferin aglycon derivative |
| 03/13/2013 | CN102153534B Compound with tyrosinase inhibitory activity as well as preparation method and application thereof |
| 03/13/2013 | CN102133247B Costustoot extractive with blood sugar reduction activity and application thereof |
| 03/13/2013 | CN102091057B Preparation method of medicament-carrying biological membrane |
| 03/13/2013 | CN102058727B Ceramide-containing tea seed extract and preparation method thereof |
| 03/13/2013 | CN102050720B Novel DHA derivative and its usage as medicine |
| 03/13/2013 | CN102048884B Weight-losing composition containing guarana extract |
| 03/13/2013 | CN102000126B Ginkgo flavone tablet and preparation method thereof |
| 03/13/2013 | CN101954095B Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells |
| 03/13/2013 | CN101897948B Application of S-nitroso glutathione |
| 03/13/2013 | CN101715450B Azaindole derivatives as CFTR modulators |
| 03/13/2013 | CN101600724B Nk1 receptor antagonist composition |
| 03/13/2013 | CN101503356B Novel method for preparing high-purity chlorogenic acid |
| 03/13/2013 | CN101417124B Biocompatible material and process for manufacturing the same |
| 03/13/2013 | CN101336935B Sea cucumber extract and preparation method thereof |
| 03/13/2013 | CN101213281B 新的dha衍生物及其作为药物的用途 Dha new derivatives and their use as medicament |
| 03/12/2013 | US8394930 Growth factor isoform |
| 03/12/2013 | US8394823 Triazolopyridine compounds useful as DGAT1 inhibitors |
| 03/12/2013 | US8394817 CCR1 antagonists and methods of use therefor |
| 03/12/2013 | US8394808 HM74 receptor agonists:xanthine derivatives, corresponding pharmaceutical compositions, treatment methods and processes |
| 03/12/2013 | US8394766 Cellular activation insulin therapy |
| 03/12/2013 | US8394629 Use of vinca alkaloids and salts thereof |
| 03/12/2013 | US8394401 Antiobesity or antihyperlipidemic food, feeding stuff or supplement containing lysine |
| 03/12/2013 | US8394369 Chondrocyte therapeutic delivery system |
| 03/12/2013 | US8394361 Stable surfactant compositions for suspending components |
| 03/12/2013 | CA2706661C Intermediates for the preparation of lipoxin a4 analogs |
| 03/12/2013 | CA2699568C Azaindoles |
| 03/12/2013 | CA2697551C Piperidine derivatives as modulators of gpr119 activity |
| 03/12/2013 | CA2695088C Novel piperazine amide derivatives |
| 03/12/2013 | CA2680946C Pim-3 kinase as a target for type 2 diabetes mellitus |
| 03/12/2013 | CA2551227C Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies |
| 03/12/2013 | CA2473927C Methods and compositions for treating polycystic ovary syndrome |
| 03/12/2013 | CA2464111C Phosphonic acid compounds as inhibitors of serine proteases |
| 03/12/2013 | CA2464092C Electroprocessing in drug delivery and cell encapsulation |
| 03/12/2013 | CA2388505C 5-membered heterocycle derivatives, their preparation and application as medicine |
| 03/12/2013 | CA2369908C Protein/polypeptide-k obtained from momordica charantia and a process for the extraction thereof |
| 03/07/2013 | WO2013033675A1 Chimeric natriuretic peptide compositions and methods of preparation |
| 03/07/2013 | WO2013033602A2 Fatty acid amides, compositions and methods of use |
| 03/07/2013 | WO2013033432A1 Methods and compositions for treating type 2 diabetes and related conditions |
| 03/07/2013 | WO2013033283A1 Improving systemic glucose tolerance in type-2 diabetes |
| 03/07/2013 | WO2013033167A1 Compounds and compositions as c-kit kinase inhibitors |
| 03/07/2013 | WO2013033116A1 Compounds and compositions as c-kit kinase inhibitors |
| 03/07/2013 | WO2013033070A1 COMPOUNDS AND COMPOSITIONS AS c-KIT KINASE INHIBITORS |
| 03/07/2013 | WO2013032939A1 Bicyclic agonists of gpr131 and uses thereof |
| 03/07/2013 | WO2013032328A1 Method for preventing and/or treating insulin resistance |
| 03/07/2013 | WO2013032012A1 Glycosylated polypeptide and drug composition containing said polypeptide |
| 03/07/2013 | WO2013032011A1 Glycosylated polypeptide and drug composition containing said polypeptide |
| 03/07/2013 | WO2013031922A1 Pyrazole compound and use thereof for medical purposes |
| 03/07/2013 | WO2013031729A1 Prophylactic/therapeutic agent for cardiovascular complications of diabetes |
| 03/07/2013 | WO2013030218A1 Selective and reversible inhibitors of ubiquitin specific protease 7 |
| 03/07/2013 | WO2013029279A1 Novel glp-i analogue, preparation method and use thereof |
| 03/07/2013 | WO2013010137A3 A composition, device and method for delayed and sustained release of brain energy molecules |
| 03/07/2013 | WO2012144854A3 Novel uses of licochalcone a |
| 03/07/2013 | WO2012138919A9 Method of treating or ameliorating metabolic disorders using growth differentiation factor 15 (gdf-15) |
| 03/07/2013 | WO2012004273A3 Array of age-tailored nutritional formula with optimum fat content |
| 03/07/2013 | US20130059917 Modified release dosage form comprising desvenlafaxine or salts thereof |
| 03/07/2013 | US20130059912 Nitrated-fatty acids modulation of type ii diabetes |
| 03/07/2013 | US20130059908 Sulfonamides for the prevention of diabetes |
| 03/07/2013 | US20130059891 Substituted n-heterocycloalkyl bipyrrolidinylphenyl amide derivatives, preparation and therapeutic use thereof |
| 03/07/2013 | US20130059887 Substituted pyridoxine-lactam carboxylate salts |
| 03/07/2013 | US20130059885 Method For Preparation Of Pitavastatin and Pharmaceutical Acceptable Salts Thereof |
| 03/07/2013 | US20130059884 Inhibitor of the differentiation of t cells into th1 cells |
| 03/07/2013 | US20130059883 Compounds and methods |
| 03/07/2013 | US20130059874 Substituted n-phenyl spirolactam bipyrrolidines, preparation and therapeutic use thereof |
| 03/07/2013 | US20130059873 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 03/07/2013 | US20130059872 Polymorphs of alogliptin benzoate |
| 03/07/2013 | US20130059871 Pyrimidine derivatives for the treatment of amyloid-related diseases |
| 03/07/2013 | US20130059863 Substituted n-heteroaryl spirolactam bipyrrolidines, preparation and therapeutic use thereof |
| 03/07/2013 | US20130059858 Benzofuranyl analogues as gpr119 modulators |
| 03/07/2013 | US20130059856 Agonists of gpr131 and uses thereof |
| 03/07/2013 | US20130059852 Compounds for treating disease, for administering, and for pharmaceutical compositions |
| 03/07/2013 | US20130059848 Cannabinoid-2 agonists |
| 03/07/2013 | US20130059846 Compounds and compositions as c-kit kinase inhibitors |
| 03/07/2013 | US20130059845 Bicyclic agonists of gpr131 and uses thereof |
| 03/07/2013 | US20130059834 Pyrrolopyrazine kinase inhibitors |
| 03/07/2013 | US20130059832 Compounds and compositions as c-kit kinase inhibitors |
| 03/07/2013 | US20130059830 Novel prolylcarboxypeptidase inhibitors |
| 03/07/2013 | US20130059828 Pharmaceutical composition |
| 03/07/2013 | US20130059821 Bicyclic aryl sphingosine 1-phosphate analogs |
| 03/07/2013 | US20130059817 Composition for reducing absorption of dietary fat |
| 03/07/2013 | US20130059816 Compositions and methods for treatment of autoimmune and other disease |